SARS-CoV-2 vaccines based on the spike glycoprotein and implications of new viral variants

D Martínez-Flores, J Zepeda-Cervantes… - Frontiers in …, 2021 - frontiersin.org
Coronavirus 19 Disease (COVID-19) originating in the province of Wuhan, China in 2019, is
caused by the severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2), whose …

COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask …

K Escandón, AL Rasmussen, II Bogoch… - BMC infectious …, 2021 - Springer
Scientists across disciplines, policymakers, and journalists have voiced frustration at the
unprecedented polarization and misinformation around coronavirus disease 2019 (COVID …

[HTML][HTML] Multiple early factors anticipate post-acute COVID-19 sequelae

Y Su, D Yuan, DG Chen, RH Ng, K Wang, J Choi, S Li… - Cell, 2022 - cell.com
Post-acute sequelae of COVID-19 (PASC) represent an emerging global crisis. However,
quantifiable risk factors for PASC and their biological associations are poorly resolved. We …

SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study …

VJ Hall, S Foulkes, A Charlett, A Atti, EJM Monk… - The Lancet, 2021 - thelancet.com
Background Increased understanding of whether individuals who have recovered from
COVID-19 are protected from future SARS-CoV-2 infection is an urgent requirement. We …

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

K Röltgen, AE Powell, OF Wirz, BA Stevens… - Science …, 2020 - science.org
SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding
domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can …

COVID-19 reinfections among naturally infected and vaccinated individuals

S Rahman, MM Rahman, M Miah, MN Begum… - Scientific reports, 2022 - nature.com
The protection against emerging SARS-CoV-2 variants by pre-existing antibodies elicited
due to the current vaccination or natural infection is a global concern. We aimed to …

[HTML][HTML] Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity

D Yahav, D Yelin, I Eckerle, CS Eberhardt… - Clinical Microbiology …, 2021 - Elsevier
By the beginning of November 2020, almost 50 million cases of coronavirus disease 2019
(COVID-19) had been reported worldwide, with over 35 million people defined as recovering …

Reinfection in patients with COVID-19: a systematic review

X Ren, J Zhou, J Guo, C Hao, M Zheng… - Global health research …, 2022 - Springer
Background With the continuation of the COVID-19 pandemic, some COVID-19 patients
have become reinfected with the virus. Viral gene sequencing has found that some of these …

Do antibody positive healthcare workers have lower SARS-CoV-2 infection rates than antibody negative healthcare workers? Large multi-centre prospective cohort …

V Hall, S Foulkes, A Charlett, A Atti, EJM Monk… - Medrxiv, 2021 - medrxiv.org
Background There is an urgent need to better understand whether individuals who have
recovered from COVID-19 are protected from future SARS-CoV-2 infection. Methods A large …

Infection and transmission of ancestral SARS-CoV-2 and its alpha variant in pregnant white-tailed deer

K Cool, NN Gaudreault, I Morozov… - Emerging microbes & …, 2022 - Taylor & Francis
ABSTRACT SARS-CoV-2 was first reported circulating in human populations in December
2019 and has since become a global pandemic. Recent history involving SARS-like …